Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,568 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysis.
Joseph P, Roshandel G, Gao P, Pais P, Lonn E, Xavier D, Avezum A, Zhu J, Liu L, Sliwa K, Gamra H, Bangdiwala SI, Teo K, Diaz R, Dans A, Lopez-Jaramillo P, Prabhakaran D, Castellano JM, Fuster V, Rodgers A, Huffman MD, Bosch J, Dagenais GR, Malekzadeh R, Yusuf S; Polypill Trialists' Collaboration. Joseph P, et al. Among authors: fuster v. Lancet. 2021 Sep 25;398(10306):1133-1146. doi: 10.1016/S0140-6736(21)01827-4. Epub 2021 Aug 29. Lancet. 2021. PMID: 34469765
Platelet inhibitor agents in cardiovascular disease: an update.
Stein B, Fuster V, Israel DH, Cohen M, Badimon L, Badimon JJ, Chesebro JH. Stein B, et al. Among authors: fuster v. J Am Coll Cardiol. 1989 Oct;14(4):813-36. doi: 10.1016/0735-1097(89)90453-1. J Am Coll Cardiol. 1989. PMID: 2677086 Free article. Review.
Usefulness of aspirin for coronary artery disease.
Fuster V, Cohen M, Chesebro JH. Fuster V, et al. Am J Cardiol. 1988 Mar 1;61(8):637-40. doi: 10.1016/0002-9149(88)90780-1. Am J Cardiol. 1988. PMID: 3278582 Clinical Trial. No abstract available.
The fixed-dose combination drug for secondary cardiovascular prevention project: improving equitable access and adherence to secondary cardiovascular prevention with a fixed-dose combination drug. Study design and objectives.
Sanz G, Fuster V, Guzmán L, Guglietta A, Arnáiz JA, Martínez F, Sarria A, Roncaglioni MC, Taubert K. Sanz G, et al. Among authors: fuster v. Am Heart J. 2011 Nov;162(5):811-817.e1. doi: 10.1016/j.ahj.2011.08.012. Am Heart J. 2011. PMID: 22093195 Clinical Trial.
Quantitative assessment of right ventricular function in pectus excavatum.
Narayan RL, Vaishnava P, Castellano JM, Fuster V. Narayan RL, et al. Among authors: fuster v. J Thorac Cardiovasc Surg. 2012 May;143(5):e41-2. doi: 10.1016/j.jtcvs.2012.01.073. Epub 2012 Feb 27. J Thorac Cardiovasc Surg. 2012. PMID: 22377665 Free article. No abstract available.
Atrial fibrillation, stroke, and quality of life.
Chinitz JS, Castellano JM, Kovacic JC, Fuster V. Chinitz JS, et al. Among authors: fuster v. Ann N Y Acad Sci. 2012 Apr;1254:140-150. doi: 10.1111/j.1749-6632.2012.06494.x. Ann N Y Acad Sci. 2012. PMID: 22548580 Review.
Are we ignoring the dilated thoracic aorta?
Castellano JM, Kovacic JC, Sanz J, Fuster V. Castellano JM, et al. Among authors: fuster v. Ann N Y Acad Sci. 2012 Apr;1254:164-174. doi: 10.1111/j.1749-6632.2012.06493.x. Ann N Y Acad Sci. 2012. PMID: 22548582 Review.
1,568 results